Screen Shot 2021-10-13 at 11.08.55 AM.png

KROUZON

Restoring Normal Child Development Without Lifelong Surgeries

 
 

About Krouzon

Krouzon Pharmaceuticals was founded by Dr. V.P. Eswarakumar, a then Associate Professor at Yale University, after 25+ years of hands-on research experience. He created the world’s first disease model for Crouzon and Pfeiffer syndromes and discovered treatment methods.

 

At Krouzon

Krouzon is developing therapeutics for children born with FGFR2-related Craniosynostosis Syndromes

Meet The Team

  • V.P. Eswarakumar, Ph.D.

  • Research & Development Team

  • Management Team